CRN00808-08: A Randomized, Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Paltusotine in Subjects with Non-pharmacologically Treated Acromegaly Study Name: PATHFNDR-2: Paltusotine Acromegaly Therapy Featuring a Non-Invasive Daily Regimen.

PI: Merav Fraenkel. Funded: pharm-olam

foresiGHt: A multicenter, randomized, parallel-arm, placebo-controlled (double-blind) and active-controlled (open-label) trial to compare the efficacy and safety of once-weekly lonapegsomatropin with once-weekly placebo and a daily somatropin product in adults with growth hormone deficiency.

PI: Merav Fraenkel. Funded: Clintrials

CRN00808-09 “A Randomized, Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Paltusotine in Subjects with Acromegaly Treated with Long acting Somatostatin Receptor Ligands”.

PI: Merav Fraenkel. Funded: Pharm-Olam